OOIR: Observatory of International Research

Papers

(The H4-Index of World Allergy Organization Journal is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
World Allergy Organization Anaphylaxis Guidance 2020	454
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee	111
COVID-19, asthma, and biological therapies: What we need to know	86
Managing food allergy: GA2LEN guideline 2022	59
Air pollution and indoor settings	58
Allergy and immunology in young children of Japan: The JECS cohort	56
Food protein-induced allergic proctocolitis in infants: Literature review and proposal of a management protocol	51
Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence	48
Relationship between blood eosinophil levels and COVID-19 mortality	44
The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources	38
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities	38
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update	34
Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review	34
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions	33
Update on latex allergy: New insights into an old problem	33
Acute asthma management during SARS-CoV2-pandemic 2020	33
A systematic review and meta-analysis of risk factors associated with atopic dermatitis in Asia	33
The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management	32
Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions	32
The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers	32
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)	30
Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD)	30
A systematic review of infant feeding food allergy prevention guidelines – can we AGREE?	28
A new form of irritant rhinitis to filtering facepiece particle (FFP) masks (FFP2/N95/KN95 respirators) during COVID-19 pandemic	27
Food labeling issues for severe food allergic patients	27

An appraisal of allergic disorders in India and an urgent call for action	27
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement	26